Schorno Dean L has filed 28 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 20636 shares of RIGEL PHARMACEUTICALS INC ($RIGL) on February 17, 2026.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | A | Common Stock | 20636 | $0.00 | 76,337.0000 | 18,840,000 | 37.05% | 0.11% |
| Feb. 10, 2026 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | F | Common Stock | 3546 | $34.62 | 55,701.0000 | 18,840,000 | 5.99% | 0.02% |
| Feb. 2, 2026 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | F | Common Stock | 5488 | $36.01 | 59,247.0000 | 18,840,000 | 8.48% | 0.03% |
| Dec. 22, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | M | Employee Stock Option (right to buy) | 1987 | $0.00 | 14,262.0000 | 19,156,000 | 12.23% | 0.01% |
| Dec. 22, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | M | Common Stock | 1667 | $18.70 | 64,235.0000 | 19,156,000 | 2.66% | 0.01% |
| Dec. 22, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | M | Common Stock | 1987 | $20.00 | 59,722.0000 | 19,156,000 | 3.44% | 0.01% |
| Dec. 22, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | M | Common Stock | 2846 | $24.20 | 62,568.0000 | 19,156,000 | 4.77% | 0.01% |
| Dec. 22, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | M | Employee Stock Option (right to buy) | 1667 | $0.00 | 10,832.0000 | 19,156,000 | 13.34% | 0.01% |
| Dec. 22, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | M | Employee Stock Option (right to buy) | 2846 | $0.00 | 17,153.0000 | 19,156,000 | 14.23% | 0.01% |
| Sept. 15, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | A | Employee Stock Option (right to buy) | 7394 | $0.00 | 7,394.0000 | 18,162,000 | 9999.99% | 0.04% |
| March 17, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | A | Employee Stock Option (right to buy) | 7850 | $0.00 | 7,850.0000 | 17,687,000 | 9999.99% | 0.04% |
| March 17, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | A | Employee Stock Option (right to buy) | 5625 | $0.00 | 5,625.0000 | 17,687,000 | 9999.99% | 0.03% |
| Feb. 4, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | S | Common Stock | 2036 | $20.92 | 58,969.0000 | 17,687,000 | 3.34% | 0.01% |
| Feb. 5, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | S | Common Stock | 1734 | $21.93 | 57,235.0000 | 17,687,000 | 2.94% | 0.01% |
| Jan. 29, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 14788 | $0.00 | 14,788.0000 | 17,687,000 | 9999.99% | 0.08% |
| Jan. 29, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | A | Common Stock | 19717 | $0.00 | 61,005.0000 | 17,687,000 | 47.75% | 0.11% |
| Nov. 25, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | A | Employee Stock Option (right to buy) | 6250 | $0.00 | 6,250.0000 | 17,648,000 | 9999.99% | 0.04% |
| Aug. 30, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | A | Employee Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 17,549,000 | 9999.99% | 0.06% |
| Feb. 28, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | A | Employee Stock Option (right to buy) | 78500 | $0.00 | 78,500.0000 | 17,401,000 | 9999.99% | 0.45% |
| Feb. 28, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | A | Employee Stock Option (right to buy) | 62500 | $0.00 | 62,500.0000 | 17,401,000 | 9999.99% | 0.36% |
| Feb. 5, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | S | Common Stock | 7027 | $1.14 | 402,891.0000 | 17,401,000 | 1.71% | 0.04% |
| Feb. 2, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | S | Common Stock | 5601 | $1.13 | 409,918.0000 | 17,401,000 | 1.35% | 0.03% |
| Jan. 23, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 157000 | $0.00 | 157,000.0000 | 17,401,000 | 9999.99% | 0.90% |
| Jan. 23, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | A | Common Stock | 209000 | $0.00 | 415,519.0000 | 17,401,000 | 101.20% | 1.20% |
| Feb. 2, 2023 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | S | Common Stock | 5389 | $1.66 | 196,519.0000 | 17,049,000 | 2.67% | 0.03% |
| Jan. 26, 2023 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | A | Employee Stock Option (right to buy) | 50000 | $0.00 | 100,000.0000 | 17,049,000 | 100.00% | 0.29% |
| Jan. 26, 2023 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | A | Common Stock | 63000 | $0.00 | 201,908.0000 | 17,049,000 | 45.35% | 0.37% |
| Jan. 26, 2023 | RIGEL PHARMACEUTICALS INC | $RIGL | Schorno Dean L | EVP & Chief Financial Officer | A | Employee Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 17,049,000 | 9999.99% | 0.73% |